...
首页> 外文期刊>Taiwanese journal of obstetrics and gynecology >The oncological and obstetric outcomes of cervical squamous cell carcinoma at stage IA1 managed with the loop electrosurgical excision procedure
【24h】

The oncological and obstetric outcomes of cervical squamous cell carcinoma at stage IA1 managed with the loop electrosurgical excision procedure

机译:宫颈鳞状细胞癌在IA1阶段的肿瘤和产科结果,采用环电外科切除术治疗

获取原文

摘要

ObjectiveTo evaluate the efficacy and superiority of loop electrosurgical excision procedure (LEEP) in managing stage IA1 cervical microinvasive squamous cell carcinoma (MISCC) without lymph-vascular space invasion (LVSI).Materials and methodsThe oncological and reproductive outcomes of a series of patients affected by stage IA1 MISCC without LVSI, initially treated by LEEP between February 2006 and December 2017, were retrospectively reviewed.ResultsUltimately, 109 patients were included. The mean age at diagnosis was 35.4 years old, and 36 patients were nulliparous. Multifocal lesions were identified in 15 patients (13.8%). The mean cone depth was 17.4?mm. Resection margins were positive/unevaluable and negative in 26 (23.9%) and 83 (76.1%) cases, respectively. Among cases undergoing salvage treatments, the residual disease rate for patients with positive/unevaluable margins was significantly higher than those with negative margins (P?=?0.003). During the follow-up period of 43.0?±?28.9 months, no relapse was identified. Fifteen of 20 patients (75.0%) conceived successfully, with a full-term live birth rate of 93.3%.ConclusionsFor stage IA1 MISCC without LVSI unexpectedly found in a loop excision, initial LEEP with clear margin is efficient and adequate. For cases with multifocal MISCC, or for those young patients who wish to become pregnant in the future, LEEP is the optimal choice.
机译:ObjectiveTo评估Loop电外科切除手术(LEEP)在没有淋巴血管空间侵袭(LVSI)的阶段Ia1宫颈微生物鳞状细胞癌(MISCC)中的疗效和优越性。物品和方法的一系列患者的肿瘤和生殖结果没有LVSI的阶段IA1 Miscc在2006年2月至2017年2月至2017年12月期间初始审查,审查了109名患者。诊断的平均年龄为35.4岁,36名患者是乏味的。在15名患者中鉴定多灶性病变(13.8%)。平均锥深度为17.4Ωmm。切除边缘分别为26(23.9%)和83例(76.1%)阳性/不值易理和阴性。在进行持续的持续处理后,阳性/不值为余量患者的残留疾病率明显高于负边缘(P?= 0.003)。在43.0的后续期间?±28.9个月,没有确定复发。十五名患者(75.0%)成功构思,具有93.3%的全学期活产率为93.3%。结论IA1 MISCCCC,没有LVSI意外地发现在循环切除中,初始LEEP具有清晰的保证金是高效和充足的。对于具有多焦点MISCC的病例,或者希望在未来怀孕的年轻患者,Leep是最佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号